Skip to main content
Log in

Identification of a novel GREM1 duplication in a patient with multiple colon polyps

  • Short Communication
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Hereditary mixed polyposis syndrome (HMPS) is a hereditary syndrome that is characterized by multiple colon polyps of mixed pathologic subtypes and an increased risk for colorectal cancer. A 40 kb duplication in the 5′ regulatory region of the GREM1 gene was recently found to be the causal mutation in a subset of Ashkenazi Jewish families with HMPS. Given this discovery, the GREM1 5′ regulatory region is now analyzed on many different multi-gene cancer panels, however the data on duplications distinct from the 40 kb duplication remains minimal. Herein we report a novel 24 kb tandem duplication of the 5′ regulatory region of GREM1 in a patient without Ashkenazi Jewish heritage, who had a family history that was concerning for Lynch syndrome and satisfied Amsterdam II criteria. This is only the third reported GREM1 duplication separate from the 40 kb Ashkenazi Jewish duplication, and is the only reported duplication to selectively involve exon 1 of GREM1. This finding supports comprehensive testing of the GREM1 regulatory region in families of all ethnicities with multiple colon polyps or colon cancer, and when Lynch syndrome is suspected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Jaeger EE, Woodford-Richens KL, Lockett M et al (2003) An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet 72(5):1261–1267. https://doi.org/10.1086/375144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Whitelaw SC, Murday VA, Tomlinson IP et al (1997) Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology 112(2):327–334

    Article  CAS  PubMed  Google Scholar 

  3. Jaeger E, Leedham S, Lewis A et al (2012) Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet 44(6):699–703. https://doi.org/10.1038/ng.2263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Rohlin A, Eiengard F, Lundstam U et al (2016) GREM1 and POLE variants in hereditary colorectal cancer syndromes. Genes Chromosomes Cancer 55(1):95–106. https://doi.org/10.1002/gcc.22314

    Article  CAS  PubMed  Google Scholar 

  5. Venkatachalam R, Verwiel ET, Kamping EJ et al (2011) Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. Int J Cancer 129(7):1635–1642. https://doi.org/10.1002/ijc.25821

    Article  CAS  PubMed  Google Scholar 

  6. Davis H, Irshad S, Bansal M et al (2015) Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche. Nat Med 21(1):62–70. https://doi.org/10.1038/nm.3750

    Article  CAS  PubMed  Google Scholar 

  7. Batts LE, Polk DB, Dubois RN, Kulessa H (2006) Bmp signaling is required for intestinal growth and morphogenesis. Dev Dyn 235(6):1563–1570. https://doi.org/10.1002/dvdy.20741

    Article  CAS  PubMed  Google Scholar 

  8. National Comprehensive Cancer Network (2017) Genetic/familial high-risk assessment: colorectal (version 2.2017). National Comprehensive Cancer Network, Fort Washington

    Google Scholar 

  9. Sopik V, Phelan C, Cybulski C, Narod SA (2015) BRCA1 and BRCA2 mutations and the risk for colorectal cancer. Clin Genet 87(5):411–418. https://doi.org/10.1111/cge.12497

    Article  CAS  PubMed  Google Scholar 

  10. National Comprehensive Cancer Network (2017) Genetic/familial high-risk assessment: breast and ovarian (version 2.2017). National Comprehensive Cancer Network, Fort Washington

    Google Scholar 

  11. Lieberman S, Walsh T, Schechter M et al (2017) Features of patients with hereditary mixed polyposis syndrome caused by duplication of GREM1 and implications for screening and surveillance. Gastroenterology 152(8):1876–1880.e1. https://doi.org/10.1053/j.gastro.2017.02.014

    Article  PubMed  Google Scholar 

  12. Ziai J, Matloff E, Choi J, Kombo N, Materin M, Bale AE (2016) Defining the polyposis/colorectal cancer phenotype associated with the Ashkenazi GREM1 duplication: counselling and management recommendations. Genet Res 98:e5. https://doi.org/10.1017/S0016672316000021

    Article  Google Scholar 

  13. Lindor NM, Rabe K, Petersen GM et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293(16):1979–1985. https://doi.org/10.1001/jama.293.16.1979

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The Lustgarten Family Colon Cancer Research Fund (AR) and NIH/NIDDK Grant 1K08DK106489 (BK).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bryson W. Katona.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McKenna, D.B., Van Den Akker, J., Zhou, A.Y. et al. Identification of a novel GREM1 duplication in a patient with multiple colon polyps. Familial Cancer 18, 63–66 (2019). https://doi.org/10.1007/s10689-018-0090-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-018-0090-6

Keywords

Navigation